The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA to weigh easing limits on unproven peptides